Expanding the body of evidence Marc Shotland Training Director and Senior Research Manager.

Slides:



Advertisements
Similar presentations
1 Policy options to address access to chronic disease medicines Dr. Richard Laing Ms. Alexandra Cameron Department of Essential Medicines and Pharmaceutical.
Advertisements

Understanding the Antimalarials Market in Uganda Rosette Mutambi, HEPS Uganda Martin Auton, Health Action International, The Netherlands ASTMH, December.
The World Bank Human Development Network Spanish Impact Evaluation Fund.
Knowing if the RBF mechanism is working Incorporating Rigorous Impact Evaluation into your HRBF program Sebastian Martinez World Bank.
Drawing policy lessons from RCTs: When to generalize and when not to Rachel Glennerster J-PAL and IGC London School of Economics, June 3, 2014.
Making Decisions in Health Care: Cost-effectiveness and the Value of Evidence Karl Claxton Centre for Health Economics, Department of Economics and Related.
Who is the subject in a CRT? Rachel Glennerster Executive Director, J-PAL Department of Economics, MIT PRIM&R November 8, 2013.
Presentation to the 2014 International AIDS Conference
1 Figure 1: Factors affecting the quality of care Impact (change in health status) Quality of Care Supply: health system Demand: expectations and needs.
Pre-analysis plans Module 8.3. Recap on statistics If we find a result is significant at the 5% level, what does this mean? – there is a 5% or less probability.
North Carolina Immunization Program (NCIP) Overview
Latest Trends in Evaluation: Interviews with Industry Leaders Don Snodgrass and Zan Northrip October 2, 2008 DAI.
1 Managing Threats to Randomization. Threat (1): Spillovers If people in the control group get treated, randomization is no more perfect Choose the appropriate.
Public Policy & Evidence: How to discriminate, interpret and communicate scientific research to better inform society. Rachel Glennerster Executive Director.
How Policy Evaluations and Performance Management are Used Maureen Pirog Rudy Professor of Public and Environmental Affairs, Indiana University Affiliated.
Building the Foundations for Better Health Health Services Organization.
1 Interpretation and use. 2 The walls inside are plastered with laboriously made graphs…
Learning from research to improve health delivery: case of Sierra Leone Rachel Glennerster (IGC Lead Academic for Sierra Leone and JPAL)
Building an Evidence base for Primary Eye Care Improving health worldwide Professor Clare Gilbert International Centre.
1 Randomization in Practice. Unit of randomization Randomizing at the individual level Randomizing at the group level –School –Community / village –Health.
Access to health care, social protection, and household costs of illness proposal Cost of illness working group INDEPTH AGM 2009, Pune.
Learning from RBF Implementation Dinesh Nair Sr Health Specialist.
12, 2916 – 5 th Avenue Calgary, Alberta, T2A 6K4, Canada Phone: + 1 (403) , Fax: + 1 (403) Website:
1 Informed Design: Supply Chain Costing for Policy Decision Making Cost-Effectiveness of Vaccine Supply Chains in Mozambique USAID | DELIVER PROJECT Critical.
1 African Development Bank Agnes Soucat, MD, Ph.D Director Department of Human Development African Development Bank Agnes Soucat, MD, Ph.D Director Department.
Randomized Control Trials for Agriculture Pace Phillips, Innovations for Poverty Action
TRANSLATING RESEARCH INTO ACTION What is Randomized Evaluation? Why Randomize? J-PAL South Asia, April 29, 2011.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
Gender and Impact Evaluation
AADAPT Workshop Latin America Brasilia, November 16-20, 2009 Non-Experimental Methods Florence Kondylis.
Lessons for Education in Africa Evidence from Randomized Evaluations in Kenya Esther Duflo J-PAL A B D U L L A T I F J A M E E L P O V E R T Y A C T I.
Pitfalls of Participatory Programs: Evidence from a randomized evaluation in education in India Abhijit Banerjee (MIT) Rukmini Banerji (Pratham) Esther.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Using willingness to pay data to inform the design of health insurance for the poor: evidence from micro-lending clients in Lagos, Nigeria November 1,
Cultivating Demand Within USAID for Impact Evaluations of Democracy and Governance Assistance Mark Billera USAID Office of Democracy and Governance Perspectives.
Expanded Program of Immunization Dr. Faten M. Rabie.
Immunization service delivery – immunization management prospective.
Influenza Vaccination Campaign 2003 Dr. Michael Koller QI Director for Primary Care.
Reactive Power Federal Energy Regulatory Commission Open Meeting December 15, 2004.
CAUSAL INFERENCE Shwetlena Sabarwal Africa Program for Education Impact Evaluation Accra, Ghana, May 2010.
Inaugural Conference of the African Health Economics and Policy Association (AfHEA) Accra - Ghana, 10th - 12th March 2009 Economic Evaluation of Flying.
Community Health Development Project in Long Reap Hoi 1 Members 1.Mr.Nalong Bouchaleune (Lao PDR) 2.Ms.Win Pa Pa Soe (Myanmar) 3.Mr.Kirati pong Punyaruang.
CLICK TO ADD TITLE [DATE][SPEAKERS NAMES] The 5th Global Health Supply Chain Summit November , 2012 Kigali, Rwanda NGO Social Responsibility Model.
Africa Impact Evaluation Program on AIDS (AIM-AIDS) Cape Town, South Africa March 8 – 13, Causal Inference Nandini Krishnan Africa Impact Evaluation.
Impact Evaluation Designs for Male Circumcision Sandi McCoy University of California, Berkeley Male Circumcision Evaluation Workshop and Operations Meeting.
Yemaneberhan Taddesse.  PASDEP(plan of accelerated and sustainable development for the Eradication of poverty) Poverty reduction strategy is the main.
Nigeria Impact Evaluation Community of Practice Abuja, Nigeria, April 2, 2014 Measuring Program Impacts Through Randomization David Evans (World Bank)
Paulin Basinga Rwanda School of Public Health Christel Vermeersch World Bank A collaboration between the Rwanda Ministry of Health, CNLS, SPH, INSP Mexico,
Better Decision-Making with RCTs: A Guide for Financial Service Providers.
Promoting Quality Care Dr. Gwen Hollaar. Introduction We all want quality in health care –Communities –Patients –Health Care Workers –Managers –MOH /
1 Micro Health Insurance The research perspective Lakshmi Krishnan Centre for Micro Finance, IFMR (Chennai) May
How computerized immunization information systems can improve Vaccine Stock Management WHO EURO lessons learned Using information and communication technology.
Mary Koslap-Petraco DNP, PNP-BC, CPNP Coordinator-Suffolk County Department of Health Services Hauppauge, NY.
[Presentation location] [Presentation date] (Confirm ABT logo) Building Bridges and Bonds (B3): An introduction.
Cross-Country Workshop for Impact Evaluations in Agriculture and Community Driven Development Addis Ababa, April 13-16, Causal Inference Nandini.
Theory of change Francis Rathinam, Evaluation Specialist
Overview J-PAL specialises in impact evaluations of social programmes that make use of a randomised counterfactual Because.
Right-sized Evaluation
Procurement and Supply Management for iCCM – common challenges
Health Care Financing: User Fees
Partnership USAID The World Bank John Snow Inc. DFID MOH Crown Agents.
Vaccination Strategies
MANAGEMENT, STAFF, NATIONAL COALITION, FINANCIAL RESOURCES,
1 Causal Inference Counterfactuals False Counterfactuals
A collective impact organization of 181 members that help and support children and young people in need of care and guidance. Our members are present.
MAMaZ Against Malaria, Zambia
MANAGEMENT, STAFF, NATIONAL COALITION, FINANCIAL RESOURCES,
Impact Evaluation Designs for Male Circumcision
World Health Organization
The microplanning process as currently implemented in Myanmar
Presentation transcript:

Expanding the body of evidence Marc Shotland Training Director and Senior Research Manager

J-PAL What is…. 2

What is J-PAL? Research center within the Economics Department of MIT A network of 51 affiliated professors 3

A Research Network 4 Esther Duflo Abhijit Banerjee Rachel Glennerster

J-PAL Offices 5

J-PAL Mission Evaluate: Conduct Randomized evaluations to learn how to improve the lives of the poor Build Capacity: Train others to conduct randomized evaluations Impact Policy: Advocate for evidence-based policy 6

EVALUATION 7

J-PAL Projects J-PAL has 250 completed and ongoing evaluations in 43 countries 48 complete evaluations in Health

EVALUATE Why do we….

Puzzles in delivery and take-up Vaccinations or treatments exist People aren’t getting vaccinated or treated Why? – Supply chain is breaking down – “Demand chain” is breaking down

Example: Immunization in rural Rajasthan Vaccinations were free Provided by public health facilities As of baseline, only 2% of children received the full course of immunizations Health care center is “always” closed

Gov/NGO procures sufficient vaccines & distributes to facilities Facility has appropriate (non-expired) dose in stock Immunizations provided to patient (at minimal cost) Staff provide patients w/ guidance on requirements to complete full course Patient receives full course of immunizations Start with a mapping of successful program from supply- side (usually from mixed methods research)… Generating hypotheses to test with RCTs Functional supply chain

And then demand-side… Functional demand chain Patient willing/able to pay for vaccination Patient promptly visits quality provider Patient seeks immunizations Patient accepts vaccination & completes full course Patient receives full course of immunizations

Opportunity cost high due to distance & queue for service User fees high Supply chain irregular & insufficient Poor inventory management Then consider how this might break down… Gov/NGO procures sufficient vaccines & distributes to facilities Facility has appropriate (non-expired) dose in stock Immunizations provided to patient at minimal cost Staff provide patients w/ guidance on requirements to complete full course Patient receives full course of immunizations

Unaware of vaccination options Unaware of why they need immunizations Don’t believe that immunizations are effective Quality treatment is uncertain/ inaccessible due to: geographic proximity stock outs poor provider attendance, quality & training Vaccination is unaffordable Unable to afford full course Do not complete full course due to: procrastination inconvenience forgetfulness Breakdown in Demand Chain Patient willing/able to pay for vaccination Patient promptly visits quality provider Patient seeks immunizations Patient accepts vaccination & completes full course Patient receives full course of immunizations

Immunization in rural Rajasthan Uncertain Supply – Seva Mandir introduces “immunization camps” – Open from 11am-2pm on a fixed date Demand (incentives) – Offered 1kg dal per immunization administered – a set of thalis (metal meal plates) upon completion of a child’s full immunization course

Immunization Supply and Demand 17 Full Course Immunizations

Why rigorous impact evaluation? 1.Determine the impact of your policy 2.Ensure your impact estimate is valid 18 Poor inventory management Gov/NGO procures sufficient vaccines & distributes to facilities Facility has appropriate (non-expired) dose in stock Immunizations provided to patient at minimal cost Staff provide patients w/ guidance on requirements to complete full course Patient receives full course of immunizations

What is Impact? 19 Time Primary Outcome Counterfactual Intervention

What is Impact? 20 Time Primary Outcome Counterfactual Intervention

What is Impact? 21 Time Primary Outcome Counterfactual Intervention

How should we measure impact? 22 Impact is defined as a comparison between: 1.the outcome some time after the program has been introduced --and-- 2.the outcome at that same point in time had the program not been introduced (the “counterfactual”) Problem: Counterfactual cannot be observed Solution: We need to “mimic” or construct the counterfactual

Why Experiment? 23

Why Experiment? 24

Randomization allows meaningful comparisons Determine different treatment group randomly By design, program beneficiaries are not more motivated, richer, more educated than others Gives nice clean result everyone can understand 25

J-PAL’s Mission 26